Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SMI481 (NPPM6748481) 是一种选择性的酵母磷脂酰肌醇转移蛋白 (PITP) Sec14 抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 280 | 现货 | ||
10 mg | ¥ 413 | 现货 | ||
25 mg | ¥ 578 | 现货 | ||
50 mg | ¥ 828 | 现货 | ||
100 mg | ¥ 1,330 | 现货 | ||
500 mg | ¥ 3,330 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 297 | 现货 |
产品描述 | SMI481 (NPPM6748481) is the first small-molecule Sec14-like phosphatidylinositol transfer proteins (PITPs) inhibitor. |
体外活性 | Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production and are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like PITPs nor PITPs in general have been exploited as targets for chemical inhibition for such purposes. Herein, we validate what is to our knowledge the first small-molecule inhibitors (SMIs) of the yeast PITP Sec14. These SMIs are nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs) and are effective inhibitors in vitro and in vivo. We further establish that Sec14 is the sole essential NPPM target in yeast and that NPPMs exhibit exquisite targeting specificities for Sec14 (relative to related Sec14-like PITPs), propose a mechanism for how NPPMs exert their inhibitory effects and demonstrate that NPPMs exhibit exquisite pathway selectivity in inhibiting phosphoinositide signaling in cells. These data deliver proof of concept that PITP-directed SMIs offer new and generally applicable avenues for intervening with phosphoinositide signaling pathways with selectivities superior to those afforded by contemporary lipid kinase-directed strategies. |
别名 | NPPM-6748-481, NPPM 6748-481, NPPM6748481, SMI-481 SMI 481, NPPM 6748481 |
分子量 | 363.77 |
分子式 | C17H15ClFN3O3 |
CAS No. | 432020-20-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (151.19 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.749 mL | 13.7449 mL | 27.4899 mL | 68.7247 mL |
5 mM | 0.5498 mL | 2.749 mL | 5.498 mL | 13.7449 mL | |
10 mM | 0.2749 mL | 1.3745 mL | 2.749 mL | 6.8725 mL | |
20 mM | 0.1374 mL | 0.6872 mL | 1.3745 mL | 3.4362 mL | |
50 mM | 0.055 mL | 0.2749 mL | 0.5498 mL | 1.3745 mL | |
100 mM | 0.0275 mL | 0.1374 mL | 0.2749 mL | 0.6872 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SMI481 432020-20-7 Others NPPM-6748-481 NPPM 6748-481 Inhibitor NPPM6748481 SMI-481 SMI481 SMI-481 SMI 481 SMI-481 SMI-481 NPPM-6748481 SMI-481 NPPM 6748481 SMI 481 inhibit inhibitor